Literature DB >> 12962167

Wilson disease.

Mounif El-Youssef1.   

Abstract

Wilson disease is a rare disorder of copper metabolism that results in accumulation of copper in the liver and subsequently in other organs, mainly the central nervous system and the kidneys. Advances in the diagnosis and treatment of Wilson disease are discussed, with the emphasis that this is a disease of children, adolescents, and young adults. The myriad manifestations of Wilson disease make its diagnosis dependent on a high index of suspicion, and determination of its genetic background is helping to elucidate the genotype-phenotype correlation and the diversity of presentations. Treatment of Wilson disease has progressed from chelation therapy using D-penicillamine and trientine to the more recent use of zinc and finally to the establishment of liver transplantation as an urgent but excellent modality for fulminant presentation. The evolution of Wilson disease from a uniformly fatal disease to an eminently treatable disease during the past century is an example of the remarkable advances of modern medicine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12962167     DOI: 10.4065/78.9.1126

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  9 in total

1.  Wilson's disease in two consecutive generations in a Bulgarian Roma family.

Authors:  V Mihaylova; T Todorov; H Jelev; S Cherninkova; M Raycheva; A Savov; I Kremensky; I Tournev
Journal:  J Neurol       Date:  2007-08-14       Impact factor: 4.849

Review 2.  Redox control of prion and disease pathogenesis.

Authors:  Neena Singh; Ajay Singh; Dola Das; Maradumane L Mohan
Journal:  Antioxid Redox Signal       Date:  2010-06-01       Impact factor: 8.401

3.  Analysis of renal impairment in children with Wilson's disease.

Authors:  Xiao-Hui Zhuang; Ying Mo; Xiao-Yun Jiang; Shu-Mei Chen
Journal:  World J Pediatr       Date:  2008-05       Impact factor: 2.764

4.  Quality of Life and Psychiatric Symptoms in Wilson's Disease: the Relevance of Bipolar Disorders.

Authors:  Mg Carta; G Mura; O Sorbello; G Farina; L Demelia
Journal:  Clin Pract Epidemiol Ment Health       Date:  2012-09-18

5.  Bipolar disorders and Wilson's disease.

Authors:  Mauro Giovanni Carta; Orazio Sorbello; Maria Francesca Moro; Krishna M Bhat; Enrico Demelia; Alessandra Serra; Gioia Mura; Federica Sancassiani; Mario Piga; Luigi Demelia
Journal:  BMC Psychiatry       Date:  2012-05-30       Impact factor: 3.630

6.  Administration of PPARβ/δ agonist reduces copper-induced liver damage in mice: possible implications in clinical practice.

Authors:  Alvaro A Sanchez-Siles; Norihisa Ishimura; Mohammad A K Rumi; Yuji Tamagawa; Satoko Ito; Shunji Ishihara; Toru Nabika; Yoshikazu Kinoshita
Journal:  J Clin Biochem Nutr       Date:  2011-05-14       Impact factor: 3.114

7.  Endocrine symptoms as the initial manifestation of Wilson's disease.

Authors:  Robert Krysiak; Gabriela Handzlik-Orlik; Boguslaw Okopien
Journal:  Yale J Biol Med       Date:  2012-06-25

Review 8.  Copper and copper proteins in Parkinson's disease.

Authors:  Sergio Montes; Susana Rivera-Mancia; Araceli Diaz-Ruiz; Luis Tristan-Lopez; Camilo Rios
Journal:  Oxid Med Cell Longev       Date:  2014-01-08       Impact factor: 6.543

9.  Sex Differences in Clinical Characteristics and Brain MRI Change in Patients With Wilson's Disease in a Chinese Population.

Authors:  Xiaohu Li; Zhiqiang Feng; Wei Tang; Xuen Yu; Yinfeng Qian; Bin Liu; Xiaoshu Li; Renmin Yang; Yongqiang Yu
Journal:  Front Physiol       Date:  2018-10-09       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.